Day 5: What is Neuroblastoma?

September 5th, 2017 by Sarah Turner Davis

Patrick Chance passed away from Neuroblastoma in 2012. Today, we learn more about Neuroblastoma and why Press On works tirelessly to find a cure.

What is Neuroblastoma?

Neuroblastoma is a type of childhood cancer that develops from early forms of nerve cells called neuroblasts. It usually begins in the adrenal gland on top of the kidney, but it can be found anywhere along the spine.

How common is it?

Neuroblastoma accounts for about 6% of all cancers in children~ There are about 1000 new cases of neuroblastoma per year in the United States.

Who can be affected by Neuroblastoma?

The average age of children when they are diagnosed is about 1 to 2 years~ Nearly 90% of cases are diagnosed by age 5. It is very rare in people over the age of 10 years.

What is the prognosis?

In about 2 of 3 cases, the disease has already spread to the lymph nodes or to other parts of the body when it is diagnosed~ Despite advances in therapy, about half the children with aggressive neuroblastoma will die from their disease.

~

From high dose chemotherapy, targeted radiation, and even bone marrow transplants, treatments for neuroblastoma are often invasive, intense, and painful. But they are often still not enough. Press On has provided grants to several innovative neuroblastoma projects at hospitals across the country, including Children’s Hospital of Los Angeles, St. Jude Children’s Research Hospital, Children’s Hospital of Philadelphia, Memorial Sloan Kettering, and Children’s Healthcare of Atlanta. Read more about these and other projects funded by Press On here.


P.S. Our goals for ACTION are so audacious they literally cannot be achieved without your help. For the entire month of September, every dollar donated to Press On ~ up to $250,000! ~ will be MATCHED for Target Pediatric AML (“TpAML”), a MOONSHOT project aimed at identifying genomic targets for pediatric Acute Myeloid Leukemia patients so that researchers can create specific, targeted treatments. These targeted ~ and consequently less toxic ~ treatments FOR KIDS are what Press On is all about! Please, if you are comfortable doing so, take just a few minutes of your time to DONATE NOW and SHARE today’s blog post on your Facebook page, or share via personal email with friends whom you believe have the passion to help us make a difference.

Thank you for supporting the Press On Fund!

DONATE NOW

Leave a Reply

Your email address will not be published.